Showing 991-1000 of 1560 results for "".
- Beyond the Impact: New Insights into CTE and Contact Sport Safetyhttps://reachmd.com/news/beyond-the-impact-new-insights-into-cte-and-contact-sport-safety/2484271/Single‑cell genomic studies now implicate somatic neuronal mutations and persistent immune activation — not just repetitive head impacts — in chronic traumatic encephalopathy (CTE), a
- POWER4 Data: Anemia Flags Risk but Isn’t a Confirmed Driver of Recurrencehttps://reachmd.com/news/power4-data-anemia-flags-risk-but-isnt-a-confirmed-driver-of-recurrence/2484028/The multicenter POWER4 cohort analysis reports that preoperative anemia and perioperative red blood cell transfusion associate with worse disease-free survival on univariable
- EPG5 Mutations Link Autophagy Dysfunction to Neurodevelopmental and Neurodegenerative Disordershttps://reachmd.com/news/epg5-mutations-link-autophagy-dysfunction-to-neurodevelopmental-and-neurodegenerative-disorders/2483924/Autophagy—cells’ built‑in waste disposal and recycling system—is essential for neural health, and its failure is increasingly implicated in both developmental and degenerative brain diseases.
- COVID-19 Rates Oscillate Every 6 Months in the US, New Study Showshttps://reachmd.com/news/covid-19-rates-oscillate-every-6-months-in-the-us-new-study-shows/2468197/Transmission electron microscope image of SARS-CoV-2, the virus that causes COVID-19, emerging from human cells. Credit: NIAID
- Scientists Unlock the Secret Behind a Decades-Old Dengue Mysteryhttps://reachmd.com/news/scientists-unlock-the-secret-behind-a-decades-old-dengue-mystery/2468075/Allyson Choi examining cell cultures in the lab. Credit: Duke-NUS Medical School Like many good detectives, Duke-NUS Integra
- Lonsurf and Talzenna for Cancers with TP53 Mutationshttps://reachmd.com/news/lonsurf-and-talzenna-for-cancers-with-tp53-mutations/2467741/April 4, 2024, by Nadia Jaber Researchers have identified a drug combination that selectively kills cancer cells with mutations in the TP53 gene. Such mutations are f
- Senolytics: From Pharmacological Inhibitors to Immunotherapies, a Promising Future for Patients’ Treatment - NPJ Aginghttps://reachmd.com/news/senolytics-from-pharmacological-inhibitors-to-immunotherapies-a-promising-future-for-patients-treatment-npj-aging/2467332/Hernandez-Segura, A., Nehme, J. & Demaria, M. Hallmarks of Cellular Senescence. Trends Cell Biol. 28, 436–453 (2018).Article
- The Molecule That Could Alleviate Stroke-Related Brain Injuryhttps://reachmd.com/news/the-molecule-that-could-alleviate-stroke-related-brain-injury/2467300/Pictured above: Live (blue) and dead (red) neurons without (left) or with (right) treatment with LK-2, showing that the molecule reduces cell death.
- Researchers Unveil Shared and Unique Brain Molecular Dysregulations in PTSD and Depressionhttps://reachmd.com/news/researchers-unveil-shared-and-unique-brain-molecular-dysregulations-in-ptsd-and-depression/2463179/This illustration depicts a single cell RNA-sequencing study of PTSD, major depression and normal controls. In this plot, more than 363,000 nuclei are represented and categorized into eig
- Massive Study Identifies New Biomarkers for Renal Cancer Subtypes, Improving Diagnosis and—Eventually—Treatmenthttps://reachmd.com/news/massive-study-identifies-new-biomarkers-for-renal-cancer-subtypes-improving-diagnosis-andeventuallytreatment/2462965/A study led by University of Michigan Health Rogel Cancer Center researchers identifies novel biomarkers in renal cell carcinomas. The researchers’ integrative analysis of